| Patricia Estela Blumenreich, MD | |
|
540 E 1st St, Waconia, MN 55387-1601 | |
| (952) 442-4437 | |
| (952) 442-3084 |
| Full Name | Patricia Estela Blumenreich |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 540 E 1st St, Waconia, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700888211 | NPI | - | NPPES |
| 1524334 | Other | MN | UBH MEDICA |
| HP30289 | Other | MN | HEALTH PARTNERS |
| 1015941 | Other | MN | PREFERRED ONE |
| 737018100 | Medicaid | MN | |
| 121372 | Other | MN | U CARE |
| 82D10BL | Other | MN | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 38113 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Estela Blumenreich, MD 540 E 1st St, Waconia, MN 55387-1601 Ph: (952) 442-4437 | Patricia Estela Blumenreich, MD 540 E 1st St, Waconia, MN 55387-1601 Ph: (952) 442-4437 |
News Archive
The PRACTISE intervention to boost stroke thrombolysis rates is not just cost-effective, but cost-saving, show the results of a prespecified analysis.
Chicago-based Beltone Electronics recently announced the introduction of the Beltone True™, a new generation of virtually invisible hearing instruments that wirelessly receive sound directly from TV, cell/home phone, stereo, PC, iPod or any audio device via a 2.4 GHz signal.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
A new technique developed by researchers at Lawrence Livermore National Lab promises to improve accuracy and lower costs of real-time assessment of kidney function, reports an article published this week by SPIE, the international society for optics and photonics, in the Journal of Biomedical Optics.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 9 days ago
Kevin Nathaniel Brown, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 560 S Maple St Ste 400, Waconia, MN 55387 Phone: 952-442-8011 Fax: 952-442-7852 | |
Bruce Harold Hiller, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 540 E 1st St, Waconia, MN 55387 Phone: 952-442-4437 Fax: 952-442-3084 | |
William Howard Hague, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 540 E 1st St, Waconia, MN 55387 Phone: 952-442-4437 Fax: 952-442-3084 |